- Home
- CAC vs PLRX Comparison
CAC vs PLRX Comparison
Compare CAC & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- PLRX
- Stock Information
- Founded
- CAC 1875
- PLRX 2015
- Country
- CAC United States
- PLRX United States
- Employees
- CAC N/A
- PLRX N/A
- Industry
- CAC Major Banks
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- PLRX Health Care
- Exchange
- CAC Nasdaq
- PLRX Nasdaq
- Market Cap
- CAC N/A
- PLRX 77.3M
- IPO Year
- CAC 1997
- PLRX 2020
- Fundamental
- Price
- CAC $42.28
- PLRX $1.44
- Analyst Decision
- CAC Hold
- PLRX Hold
- Analyst Count
- CAC 3
- PLRX 10
- Target Price
- CAC $47.33
- PLRX $9.79
- AVG Volume (30 Days)
- CAC 70.1K
- PLRX 1.7M
- Earning Date
- CAC 07-29-2025
- PLRX 08-06-2025
- Dividend Yield
- CAC 3.96%
- PLRX N/A
- EPS Growth
- CAC 2.54
- PLRX N/A
- EPS
- CAC 3.09
- PLRX N/A
- Revenue
- CAC $184,324,000.00
- PLRX N/A
- Revenue This Year
- CAC $40.83
- PLRX N/A
- Revenue Next Year
- CAC $5.29
- PLRX N/A
- P/E Ratio
- CAC $13.75
- PLRX N/A
- Revenue Growth
- CAC 13.26
- PLRX N/A
- 52 Week Low
- CAC $34.53
- PLRX $1.10
- 52 Week High
- CAC $50.07
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- CAC 57.43
- PLRX 54.38
- Support Level
- CAC $41.12
- PLRX $1.32
- Resistance Level
- CAC $43.51
- PLRX $1.48
- Average True Range (ATR)
- CAC 0.94
- PLRX 0.11
- MACD
- CAC -0.05
- PLRX 0.02
- Stochastic Oscillator
- CAC 66.07
- PLRX 78.08
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.